Vol.74 No.6 November 2026
A case of spondylodiscitis caused by Abiotrophia defectiva that was successfully treated by ampicillin monotherapy
1)Department of Pharmacy, Kishiwada City Hospital, 1001 Gakuhara, Kishiwada, Osaka, Japan
2)Department of Clinical Laboratory, Kishiwada City Hospital
3)Department of Gastroenterology, Kishiwada City Hospital
Abstract
Abiotrophia defectiva is a nutritionally variant Gram-positive coccus that primarily colonizes the oral cavity. Although numerous cases of infective endocarditis (IE) caused by this organism have been reported, spondylodiscitis caused by A. defectiva is rare. In addition, most previously reported cases of spondylodiscitis caused by A. defectiva were complicated by IE and treated by antimicrobial combination therapy. Herein, we report a case of A. defectiva spondylodiscitis that was successfully treated by ampicillin (ABPC) monotherapy.
The patient was a 76-year-old man who was receiving dual antithrombotic therapy and had a history of habitual gingival bleeding. He initially presented to a previous hospital with fever and low back pain; however, non-contrast computed tomography showed no findings suggestive of spondylitis, and he was subsequently referred to our hospital. Blood cultures at our hospital grew A. defectiva, and we initiated the patient on ABPC therapy, which resulted in improvement of both the fever and low back pain. Magnetic resonance imaging established the diagnosis of spondylodiscitis, whereas transesophageal echocardiography showed no vegetations, no severe valvular regurgitation, and no other findings suggestive of IE. Because the isolate showed favorable susceptibility to ABPC, the patient was treated with ABPC for 58 days and the patient was discharged with clinical improvement.
Although the susceptibility rates of A. defectiva to penicillin-based antimicrobial agents have declined in recent years, the present case suggests that ABPC monotherapy could still be an effective therapeutic option for patients with spondylodiscitis caused by A. defectiva when the isolate is identified as showing favorable susceptibility and the likelihood of IE is low.
Key word
Abiotrophia defectiva, spondylodiscitis, ampicillin, monotherapy
Received
March 27, 2026
Accepted
June 25, 2026
Jpn. J. Chemother. 74 (6): 762-769, 2026


